Portea Medical, certainly one of India’s greatest platforms for home healthcare visits, has raised $26 million in Series C investment to extend its provider vary. The spherical was once led by way of Sabre Partners and MEMG CDC, with participation from returning buyers Accel (which led Portea’s Series B two years in the past), the World Bank Group’s International Finance Corporation and Qualcomm Ventures.
Portea has now raised a complete of about $72.five million. In a press observation, Sabre Partners founder and managing spouse Rajiv Maliwal mentioned Portea Medical “has played a key role in establishing the concept of consumer-led healthcare and we look forward to working with them as they continue to transform healthcare services in India beyond the hospital space.”
The call for for home healthcare is rising temporarily in India, because of elements like an getting older inhabitants and social adjustments that implies fewer working-age adults are ready to function full-time caretakers for aged kin. Some of Portea Medical’s primary competition come with Nightingales Home Health Services, Healthcare At Home and Care24.
One of Portea’s specialities is an eldercare plan this is billed every year, since assisted dwelling communities are a reasonably new thought in India. Since its release, it’s expanded its core choices into 3 different segments: number one care, continual illness control and post-operative care.
Portea companions with healthcare suppliers, together with 50 hospitals, to permit home visits for sufferers who would possibly have hassle touring for checkups, just like the aged or bodily disabled, or simply need to steer clear of overcrowded hospitals. Its different merchandise come with lab checks the place samples are taken at home and collected by way of certainly one of Portea’s couriers and B2B products and services for corporations that need to supply staff with on-site vaccination systems or well being screenings. Portea claims that it has served 250,000 shoppers in 16 towns to this point.